Avadel Pharmaceuticals Reports First Quarter 2017 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/13/2026
- S&P 500 notches record-high close as rate-hike worries ease
- Oil settles down 2% on weak demand outlook, hefty US crude build
- BofA lifts server CPU TAM to $210bn+ on the rise of AI agents
- Burry doubles down on Nebius short after stock surges 34% on earnings
- JPMorgan gets bullish on Salesforce, says concerns are "overblown"
Avadel Pharma (AVDL) Reports Q1 EPS of $0.26, Offers Guidance
May 9, 2017 7:39 AM EDTAvadel Pharma (NASDAQ: AVDL) reported Q1 EPS of $0.26, versus $0.04 reported last year. Revenue for the quarter came in at $52.5 million, versus $36.2 million reported last year.
2017 Guidance
The Company is increasing its full year adjusted EPS guidance to a range of $0.30 to $0.45 per... More
